research use only

Entecavir Reverse Transcriptase inhibitor

Cat.No.S5246

Entecavir(BMS200475,SQ34676), a new deoxyguanine nucleoside analogue, is a selective inhibitor of the replication of the hepatitis B virus (HBV).
Jump to

Quality Control

Batch: Purity: 99.73%
99.73

Solubility

In vitro
Batch:

DMSO : 55 mg/mL (198.35 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 277.28 Formula

C12H15N5O3

Storage (From the date of receipt)
CAS No. 142217-69-4 -- Storage of Stock Solutions

Synonyms BMS200475,SQ34676 SMILES C=C1C(CC(C1CO)O)N2C=NC3=C2N=C(NC3=O)N

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

In vitro

For treatment of hepatitis B virus, combinations of ETV with each of the other HBV NRTI antivirals, adefovir, tenofovir, and lamivudine at 10 times their respective Cmax levels fails to result in cellular or mitochondrial toxicity, and displays no DNA polymerase gamma inhibition.

In vivo

Treatment with Entecavir in combination with AIC649, Induces tightly regulated Immunological and virological responses during active and maintenance ereatment in the woodchuck model of chronic hepatitis B.

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-01-16)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT07345624 NOT_YET_RECRUITING
Hepatitis B Virus Infection; Children; Chronic Hepatitis B
Qing-Lei Zeng
2026-01-11 PHASE4
NCT07345611 NOT_YET_RECRUITING
Hepatitis B Virus Infection; Children; Chronic Hepatitis B
Qing-Lei Zeng
2026-01-11 PHASE4
NCT07493109 RECRUITING
Diffuse Large B-Cell Lymphoma (DLBCL)
Ou Bai, MD/PHD
2026-05-30 PHASE3
NCT04942886 ENROLLING_BY_INVITATION
Hepatitis B Reactivation; Hematopoietic Stem Cell Transplantation; Antiviral Drug; HBV
Seoul St. Mary's Hospital
2021-08-21
NCT07797231 NOT_YET_RECRUITING
Chronic Hepatitis B
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
2026-09 PHASE3
NCT05905172 RECRUITING
Liver Fibrosis
Beijing Continent Pharmaceutical Co, Ltd.
2023-08-12 PHASE3

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map